Showing results (101-110 of 288) with videos related to

Sort By:
Pageof 29
Pneumologie (Stuttgart, Germany)|July 20, 1999
[Inpatient treatment costs of exacerbated chronic obstructive lung disease]K Riecke, J Eller, C Gericke, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1993
Diagnostic problems in lower respiratory tract infectionsH Lode, T Schaberg, M Raffenberg, et al.
The Journal of Infectious Diseases|November 1, 1976
Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibioticH Lode, K Grunert, P Koeppe, et al.
The American Review of Respiratory Disease|June 1, 1993
Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cellsT Schaberg, M Rau, H Stephan, et al.
Deutsche Medizinische Wochenschrift (1946)|September 3, 1976
[Pharmacokinetics and clinical experience with amikacin. A new aminoglycoside antibiotic]H Lode, K Grunert, P Koeppe, et al.
The American Journal of Medicine|November 30, 1989
Ciprofloxacin intravenous dose varianceH Lode, G Hoffken, K Borner, et al.
Infection|January 1, 1980
Significance of pleural and sputum concentrations for antibiotic therapy of bronchopulmonary infectionsH Lode, G Gruhlke, W Hallermann, et al.
European Journal of Clinical Microbiology|August 1, 1982
Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combinationG Witkowski, H Lode, G Höffken, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1985
Pharmacokinetics and serum bactericidal activity of ticarcillin and clavulanic acidG Höffken, H Tetzel, P Koeppe, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1996
Azithromycin--review of key chemical, pharmacokinetic and microbiological featuresH Lode, K Borner, P Koeppe, et al.
Pageof 29